Summary & Overview
CPT 92522: Evaluation of Speech Sound Production
CPT code 92522 represents the evaluation of speech sound production, a fundamental procedure in speech-language pathology for diagnosing articulation, phonological, apraxia, and dysarthria disorders. This code is widely used in outpatient settings by speech-language pathologists to assess patients with communication challenges. Nationally, the code is recognized by major payers including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, ensuring broad coverage for individuals seeking speech evaluation services.
This publication provides a comprehensive overview of 92522, detailing its clinical context, payer coverage, and its role in the broader landscape of speech-language pathology services. Readers will gain insights into the typical site of service, the types of clinical conditions evaluated, and how this code fits within related procedures such as treatment and group therapy. The summary also highlights relevant policy updates and benchmarks, offering a clear understanding of how 92522 is utilized across the healthcare system. The information is designed to support stakeholders in understanding the importance and scope of speech sound production evaluation in clinical practice.
CPT Code Overview
CPT code 92522 is used for the evaluation of speech sound production, including conditions such as articulation disorders, phonological process issues, apraxia, and dysarthria. This code falls under the Speech‑Language Pathology / Otorhinolaryngologic Evaluation and Procedures service type. The typical site of service for this evaluation is an outpatient setting, most often in the office of a Speech‑Language Pathologist. This assessment is a critical step in identifying and planning treatment for individuals with speech sound production difficulties.
Clinical & Coding Specifications
Clinical Context
A patient, often referred by an otolaryngologist or primary care provider, presents to a speech-language pathologist in an outpatient setting (such as a therapy office). The patient may have a history of oropharyngeal cancer, such as a malignant neoplasm of the tonsil or epiglottis, and is experiencing difficulties with speech sound production. The speech-language pathologist conducts a comprehensive evaluation to assess articulation, phonological processes, apraxia, or dysarthria. This evaluation helps determine the nature and severity of the speech disorder, guiding further treatment planning.
Coding Specifications
- Modifier
GN: Indicates that the service is part of a speech-language pathology plan of care. Used when billing speech-language pathology services to payors such as Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
| Modifier | Description |
|---|---|
GN | Speech-Language Pathology services modifier |
- Provider Taxonomies: